Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Mach7 Technologies Ltd. ( (AU:M7T) ) has shared an update.
Mach7 Technologies reported a strong performance for the second quarter of FY25, with a 15.6% increase in Contracted Annual Recurring Revenue (CARR) and a 14.1% rise in Annual Recurring Revenue (ARR) Run Rate. The company maintained a solid financial position with no debt and growing cash balances, while also announcing an on-market share buy-back of up to A$5 million as a capital management initiative. Mach7’s continued focus on customer intimacy and its ‘land and expand’ strategy have been key to its success, as demonstrated by new contracts with existing customers and a strong pipeline of opportunities for the future.
More about Mach7 Technologies Ltd.
Mach7 Technologies Limited is a company specializing in innovative medical imaging software solutions. The company focuses on cloud enablement, customer service, and interoperability, targeting integrated delivery networks (IDNs) and radiology group practices.
YTD Price Performance: 0.0%
Average Trading Volume: 4,072
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.92M
See more insights into M7T stock on TipRanks’ Stock Analysis page.
